Clinical Trial Update: A Phase II Study to Treat Advanced Malignant Glioma [Phase 2]

View source ↗

Summary

A Phase II clinical trial sponsored by Amgen evaluating a treatment for advanced malignant glioma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Glioma

Snippet

Sponsor: Amgen | Conditions: Advanced Malignant Glioma | Phase 2 | Status: COMPLETED